Skip to main content
Premium Trial:

Request an Annual Quote

Biotage Announces Employee Stock Option, Plans to Issue New Shares

NEW YORK, Feb. 22 (GenomeWeb News) - Biotage directors have authorized 549,600 employee stock options for allotment under a global option program for employees in the Biotage group - Biotage AB Global Share Option Plan 2005, the company said today.

 

Members of the group management will receive a maximum of 45,000 options each, members of the junior management will receive a maximum of 10,000 options each, other members of management and key employees will receive a maximum of 2,000 each, and other employees will receive a maximum of 400 each. The CEO and president has not been allotted any options.

 

Each option entitles the holder to buy one ordinary share at a price of SEK 11.83 ($1.50). The options have an exercise period of seven years. The holder must be an employee at the time of exercise.


The company will issue up to 640,000 warrants to subscribe for new shares to cover the employee stock option program.

 

The issue was authorized by shareholders on April 27. 

The Scan

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.

Gut Microbiomes Allow Bears to Grow to Similar Sizes Despite Differing Diets

Researchers in Scientific Reports find that the makeup of brown bears' gut microbiomes allows them to reach similar sizes even when feasting on different foods.

Finding Safe Harbor in the Human Genome

In Genome Biology, researchers present a new approach to identify genomic safe harbors where transgenes can be expressed without affecting host cell function.

New Data Point to Nuanced Relationship Between Major Depression, Bipolar Disorder

Lund University researchers in JAMA Psychiatry uncover overlapping genetic liabilities for major depression and bipolar disorder.